• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肠道定植多重耐药肠杆菌科细菌:筛查、流行病学、临床影响及定植者去定植策略。

Intestinal colonization with multidrug-resistant Enterobacterales: screening, epidemiology, clinical impact, and strategies to decolonize carriers.

机构信息

Institute for Infectious Diseases, University of Bern, Bern, Switzerland.

Graduate School of Cellular and Biomedical Sciences, University of Bern, Bern, Switzerland.

出版信息

Eur J Clin Microbiol Infect Dis. 2023 Mar;42(3):229-254. doi: 10.1007/s10096-023-04548-2. Epub 2023 Jan 21.

DOI:10.1007/s10096-023-04548-2
PMID:36680641
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9899200/
Abstract

The clinical impact of infections due to extended-spectrum β-lactamase (ESBL)- and/or carbapenemase-producing Enterobacterales (Ent) has reached dramatic levels worldwide. Infections due to these multidrug-resistant (MDR) pathogens-especially Escherichia coli and Klebsiella pneumoniae-may originate from a prior asymptomatic intestinal colonization that could also favor transmission to other subjects. It is therefore desirable that gut carriers are rapidly identified to try preventing both the occurrence of serious endogenous infections and potential transmission. Together with the infection prevention and control countermeasures, any strategy capable of effectively eradicating the MDR-Ent from the intestinal tract would be desirable. In this narrative review, we present a summary of the different aspects linked to the intestinal colonization due to MDR-Ent. In particular, culture- and molecular-based screening techniques to identify carriers, data on prevalence and risk factors in different populations, clinical impact, length of colonization, and contribution to transmission in various settings will be overviewed. We will also discuss the standard strategies (selective digestive decontamination, fecal microbiota transplant) and those still in development (bacteriophages, probiotics, microcins, and CRISPR-Cas-based) that might be used to decolonize MDR-Ent carriers.

摘要

产超广谱β-内酰胺酶(ESBL)和/或碳青霉烯酶肠杆菌科(Ent)导致的感染的临床影响在全球范围内已达到显著水平。这些多药耐药(MDR)病原体(尤其是大肠杆菌和肺炎克雷伯菌)引起的感染可能源自先前无症状的肠道定植,这也可能有利于向其他个体传播。因此,迅速识别肠道携带者以尝试预防严重的内源性感染和潜在传播是可取的。除了感染预防和控制措施外,还需要能够有效从肠道清除 MDR-Ent 的任何策略。在这篇叙述性综述中,我们总结了与 MDR-Ent 肠道定植相关的不同方面。特别是,我们将介绍基于培养和分子的筛查技术来识别携带者,不同人群中的流行率和危险因素数据,临床影响,定植时间以及在各种情况下对传播的贡献。我们还将讨论可能用于清除 MDR-Ent 携带者的标准策略(选择性消化道去污染、粪便微生物移植)和仍在开发中的策略(噬菌体、益生菌、微菌素和基于 CRISPR-Cas 的策略)。

相似文献

1
Intestinal colonization with multidrug-resistant Enterobacterales: screening, epidemiology, clinical impact, and strategies to decolonize carriers.肠道定植多重耐药肠杆菌科细菌:筛查、流行病学、临床影响及定植者去定植策略。
Eur J Clin Microbiol Infect Dis. 2023 Mar;42(3):229-254. doi: 10.1007/s10096-023-04548-2. Epub 2023 Jan 21.
2
Infections caused by extended-spectrum β-lactamase-producing Enterobacterales after rectal colonization with ESBL-producing Escherichia coli or Klebsiella pneumoniae.产超广谱β-内酰胺酶肠杆菌科细菌经产 ESBL 大肠埃希菌或肺炎克雷伯菌直肠定植后的感染。
Clin Microbiol Infect. 2020 Aug;26(8):1046-1051. doi: 10.1016/j.cmi.2019.11.025. Epub 2019 Dec 3.
3
Prevalence of CTX-M -Lactamases Producing Multidrug Resistant and among Patients Attending Bir Hospital, Nepal.尼泊尔比尔医院患者中产生CTX-Mβ-内酰胺酶的多重耐药菌的流行情况
Biomed Res Int. 2021 Jun 8;2021:9958294. doi: 10.1155/2021/9958294. eCollection 2021.
4
Multidrug-resistant Enterobacterales infections in abdominal solid organ transplantation.腹腔实质性器官移植术后的多重耐药肠杆菌科感染。
Clin Microbiol Infect. 2023 Jan;29(1):38-43. doi: 10.1016/j.cmi.2022.06.005. Epub 2022 Jun 16.
5
Sulopenem: An Intravenous and Oral Penem for the Treatment of Urinary Tract Infections Due to Multidrug-Resistant Bacteria.舒巴坦钠:一种用于治疗多重耐药菌引起的尿路感染的静脉注射和口服青霉素类药物。
Drugs. 2022 Apr;82(5):533-557. doi: 10.1007/s40265-022-01688-1. Epub 2022 Mar 16.
6
Epidemiology and molecular characterization of fecal carriage of third-generation cephalosporin-resistant Enterobacterales among elderly residents in Japan.日本老年居民中产第三代头孢菌素耐药肠杆菌科细菌粪便携带的流行病学和分子特征。
J Infect Chemother. 2022 Apr;28(4):569-575. doi: 10.1016/j.jiac.2021.12.033. Epub 2022 Jan 14.
7
Molecular epidemiology of extended-spectrum β-lactamase-, AmpC β-lactamase- and carbapenemase-producing Escherichia coli and Klebsiella pneumoniae isolated from Canadian hospitals over a 5 year period: CANWARD 2007-11.5 年间加拿大医院分离的产超广谱β-内酰胺酶、AmpC 酶和碳青霉烯酶大肠埃希菌和肺炎克雷伯菌的分子流行病学研究:CANWARD 2007-11。
J Antimicrob Chemother. 2013 May;68 Suppl 1:i57-65. doi: 10.1093/jac/dkt027.
8
Risk factors for multidrug resistance in nosocomial bacteremia caused by extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae.产超广谱β-内酰胺酶大肠埃希菌和肺炎克雷伯菌引起的医院获得性血流感染的多重耐药危险因素。
Microb Drug Resist. 2012 Oct;18(5):518-24. doi: 10.1089/mdr.2012.0067. Epub 2012 Jun 28.
9
Detection of Escherichia coli ST131 clonal complex (ST705) and Klebsiella pneumoniae ST15 among faecal carriage of extended-spectrum β-lactamase- and carbapenemase-producing Enterobacteriaceae.在产超广谱β-内酰胺酶和碳青霉烯酶的肠杆菌科细菌粪便携带中检测大肠杆菌ST131克隆复合体(ST705)和肺炎克雷伯菌ST15
J Med Microbiol. 2017 Feb;66(2):169-174. doi: 10.1099/jmm.0.000399. Epub 2017 Mar 7.
10
Risk factors for increasing multidrug resistance among extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella species.产超广谱β-内酰胺酶的大肠埃希菌和克雷伯菌属中多药耐药性增加的危险因素。
Clin Infect Dis. 2005 May 1;40(9):1317-24. doi: 10.1086/429239. Epub 2005 Mar 30.

引用本文的文献

1
Evaluation of Perioperative Risk Factors for Infection by Multidrug-Resistant Bacteria in Patients Undergoing Liver Transplantation.肝移植患者围手术期耐多药细菌感染危险因素评估
J Pers Med. 2025 Jun 10;15(6):240. doi: 10.3390/jpm15060240.
2
Construction and validation of an interpretable XGBoost machine learning model to predict ESBL positivity rates based on urinalysis data.基于尿液分析数据构建并验证可解释的XGBoost机器学习模型以预测超广谱β-内酰胺酶阳性率
Eur J Clin Microbiol Infect Dis. 2025 May 2. doi: 10.1007/s10096-025-05155-z.
3
Study on extended-spectrum beta-lactamases genes and drug resistance in patients with urinary tract infection of enterohemorrhagic Escherichia coli after bladder cancer surgery.膀胱癌术后肠出血性大肠杆菌所致尿路感染患者超广谱β-内酰胺酶基因及耐药性研究
Medicine (Baltimore). 2025 Apr 25;104(17):e42098. doi: 10.1097/MD.0000000000042098.
4
Harnessing the human gut microbiota: an emerging frontier in combatting multidrug-resistant bacteria.利用人类肠道微生物群:对抗多重耐药细菌的新前沿。
Front Immunol. 2025 Mar 17;16:1563450. doi: 10.3389/fimmu.2025.1563450. eCollection 2025.
5
Temporal Trends of Antimicrobial Resistance and Antibiotic Utilization in Australian Long-Term Care Facilities.澳大利亚长期护理机构中抗菌药物耐药性和抗生素使用的时间趋势。
Antibiotics (Basel). 2025 Feb 18;14(2):208. doi: 10.3390/antibiotics14020208.
6
Epidemiology and risk factors of expatriates returning to Switzerland colonized at the intestinal level with multidrug-resistant Enterobacterales.在肠道定植有多药耐药肠杆菌科细菌的返回瑞士的外籍人士的流行病学及危险因素
Eur J Clin Microbiol Infect Dis. 2025 Apr;44(4):1007-1014. doi: 10.1007/s10096-025-05069-w. Epub 2025 Feb 14.
7
Novel Variant of New Delhi Metallo-Beta-Lactamase () Discovered in a Clinical Strain of from the United Arab Emirates: An Emerging Challenge in Antimicrobial Resistance.在一株来自阿拉伯联合酋长国的临床分离大肠埃希菌中发现的新型新德里金属β-内酰胺酶():抗菌药物耐药性方面的一个新挑战
Antibiotics (Basel). 2024 Dec 2;13(12):1158. doi: 10.3390/antibiotics13121158.
8
Intestinal Colonization of Multidrug-Resistant Organisms: Identification and Antibiotic Susceptibility Patterns of Bacteria Isolated From Healthy Human Fecal Specimens.多重耐药菌的肠道定植:从健康人粪便标本中分离出的细菌的鉴定及抗生素敏感性模式
Cureus. 2024 Dec 2;16(12):e75006. doi: 10.7759/cureus.75006. eCollection 2024 Dec.
9
Laboratory detection of carbapenemases among Gram-negative organisms.革兰氏阴性菌中碳青霉烯酶的实验室检测
Clin Microbiol Rev. 2024 Dec 10;37(4):e0005422. doi: 10.1128/cmr.00054-22. Epub 2024 Nov 15.
10
Neonatal Colonization With Antibiotic-Resistant Pathogens in Low- and Middle-Income Countries: A Systematic Review and Meta-Analysis.中低收入国家新生儿抗生素耐药性病原体定植:系统评价和荟萃分析。
JAMA Netw Open. 2024 Nov 4;7(11):e2441596. doi: 10.1001/jamanetworkopen.2024.41596.